Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Bibliographic Details
Main Authors: Elmira R. Vagapova, Timofey D. Lebedev, Vladimir S. Prassolov
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-97281-9
id doaj-29bbb599cea84f50b7afcfcbd775548f
record_format Article
spelling doaj-29bbb599cea84f50b7afcfcbd775548f2021-09-05T11:30:30ZengNature Publishing GroupScientific Reports2045-23222021-08-011111110.1038/s41598-021-97281-9Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosisElmira R. Vagapova0Timofey D. Lebedev1Vladimir S. Prassolov2Engelhardt Institute of Molecular Biology, Russian Academy of SciencesEngelhardt Institute of Molecular Biology, Russian Academy of SciencesEngelhardt Institute of Molecular Biology, Russian Academy of Scienceshttps://doi.org/10.1038/s41598-021-97281-9
collection DOAJ
language English
format Article
sources DOAJ
author Elmira R. Vagapova
Timofey D. Lebedev
Vladimir S. Prassolov
spellingShingle Elmira R. Vagapova
Timofey D. Lebedev
Vladimir S. Prassolov
Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
Scientific Reports
author_facet Elmira R. Vagapova
Timofey D. Lebedev
Vladimir S. Prassolov
author_sort Elmira R. Vagapova
title Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_short Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_full Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_fullStr Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_full_unstemmed Publisher Correction: Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis
title_sort publisher correction: viral fibrotic scoring and drug screen based on mapk activity uncovers egfr as a key regulator of covid-19 fibrosis
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-08-01
url https://doi.org/10.1038/s41598-021-97281-9
work_keys_str_mv AT elmirarvagapova publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis
AT timofeydlebedev publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis
AT vladimirsprassolov publishercorrectionviralfibroticscoringanddrugscreenbasedonmapkactivityuncoversegfrasakeyregulatorofcovid19fibrosis
_version_ 1717814220563677184

Similar Items